Cohance Lifesciences Ltd (COHANCE) — Announcement | 5 September 2026

5 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

USFDA inspection completed with four observations issued

💡 Investor Takeaway

The inspection outcome may delay product launches but the company is actively addressing findings to maintain compliance.

Cohance Lifesciences announced that the USFDA completed an inspection of its formulation plant in Shamshabad, Telangana, from 27 August to 4 September 2026, issuing a Form FDA 483 with four observations. The company is implementing corrective and preventive actions and will respond within the stipulated timeline, reaffirming its commitment to quality and regulatory compliance.

📄 View Original Announcement (PDF)

📊 Stock Analysis — COHANCE ✨ Ask AI About This

About Cohance Lifesciences Ltd (COHANCE)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹17,473.75 CrP/E: 298.5ROE: 2.7%ROCE: 3.3%

View full COHANCE stock details →

📡 Get AI alerts when COHANCE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track COHANCE — Free

💡 Ask AI about this filing

"How will the FDA 483 observations affect upcoming product launches?""What is the expected timeline for resolving the four observations?""How does this inspection impact Cohance's relationship with US regulatory authorities?"

Ask AI Free →

📊 More COHANCE filings

Announcement — 28 September 2026Cohance Lifesciences Ltd announced that its trading window closes on 1 October 2026 for insiders and...
Announcement — 21 September 2026Cohance Lifesciences announced that the USFDA inspected its API facility in Andhra Pradesh from Sept...
🟡 Board Meeting — 18 September 2026Cohance Lifesciences invested USD 10 million in newly issued Compulsorily Convertible Preferred Stoc...
🟡 Voting Results — 17 September 2026Cohance Lifesciences held its 8th Annual General Meeting on 17 September 2026 via video conference, ...
🟡 Board Meeting — 17 September 2026Cohance Lifesciences held its 8th Annual General Meeting on 17 September 2026 via video conference, ...

See all COHANCE filings →

🔥 Also filed on 5 September 2026

MTARTECHMTAR Technologies LtdAnnual Report 544877Technocrats Plasma Systems LtdFinancial Results 519285Tarai Foods LtdFinancial Results 526827Spice Islands Industries LtdFinancial Results 539189Adhbhut Infrastructure LtdAnnual Report PARAGMILKParag Milk Foods LtdAnnual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when COHANCE files new disclosures

Track COHANCE filings, board meetings, and corporate actions. Free email alerts at 5 PM.